The ProPep system is specifically designed for use during robotic surgery. It is intended to allow surgeon to do intraoperative nerve monitoring during minimally invasive, robotic-assisted surgery for prostate cancer.
The system helps surgeons make a more informed decision about which nerve tissue to selectively preserve or remove during an operation, and also assess the integrity of the nerve during the procedure, according to the release.
ProPep Surgical is headquartered in Austin, Texas.
Related Articles on FDA Clearances:
Ultrasonix Medical Receives FDA Approval for Needle Guidance Technology
Synergetics Receives FDA Clearance for Versavit Vitrectomy System
FDA Approves First Glaucoma Stent for Cataract Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
